HHS could have jump-started this market in January or February and paid commercial manufacturers to make kits in large volumes, prioritized the clearance of tests that could run on the widest array of instruments, and guaranteed reimbursement to the commercial labs for the tests by agreeing to buy a certain volume of testing in advance.
